Surgery Partners Inc. Reaffirms 2025 Financial Outlook with Revenue Target of $3.30-$3.45 Billion and Adjusted EBITDA of $555-$565 Million

Reuters
17 Jun
Surgery Partners Inc. Reaffirms 2025 Financial Outlook with Revenue Target of $3.30-$3.45 Billion and Adjusted EBITDA of $555-$565 Million

Surgery Partners Inc., a leading owner and operator of short-stay surgical facilities, has reaffirmed its financial outlook for the year 2025. The company projects its revenues to be in the range of $3.30 billion to $3.45 billion, while its Adjusted EBITDA is expected to fall between $555 million and $565 million. The company's CEO, Eric Evans, expressed confidence in achieving these targets, citing strong first-quarter performance and favorable surgical trends. Surgery Partners plans to host an Investor Day in the second half of 2025 to discuss its growth strategy, industry trends, and plans for maximizing portfolio performance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Surgery Partners Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001638833-25-000117), on June 17, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10